Viewing Study NCT03214250


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-03-02 @ 8:18 AM
Study NCT ID: NCT03214250
Status: COMPLETED
Last Update Posted: 2022-12-23
First Post: 2017-06-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Sponsor: Parker Institute for Cancer Immunotherapy
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nivolumab View
None APX005M View
None previously untreated metastatic pancreatic adenocarcinoma View
None Gemcitabine View
None nab-Paclitaxel View